Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma

1985 • 677 citations

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

1986 • 371 citations

Non-Hodgkin's lymphoma time trends: United States and international data.

1992 • 363 citations

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

1995 • 288 citations

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1984 • 233 citations

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

1998 • 222 citations

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

1997 • 219 citations

Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.

1997 • 165 citations

Cancer Patient Survival: Surveillance, Epidemiology, and End Results Program, 1973–79

1983 • 158 citations

Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.

1998 • 158 citations

Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.

1995 • 147 citations

A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.

1992 • 95 citations

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy

1994 • 91 citations

In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.

1993 • 90 citations

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

1991 • 85 citations

P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.

1993 • 80 citations

P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL)

1994 • 65 citations

Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen

1990 • 62 citations

A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma

1991 • 59 citations

Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients

1987 • 52 citations

Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicin

1992 • 48 citations

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma

1992 • 43 citations

Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose Adriamycin-based regimens

1994 • 41 citations

Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology

1994 • 34 citations

Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart

1993 • 33 citations

VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.

1993 • 25 citations

MACOP-B vs F-MACHOP Regimen in the Treatment of High-Grade Non-Hodgkin's Lymphomas

1995 • 22 citations

Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy

1994 • 15 citations

Treatment of aggressive Non‐Hodgkin's lymphoma in the elderly

1995 • 13 citations

Serum p53 accumulation and altered antibody responses to Epstein‐Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin

1996 • 12 citations

[A retrospective comparison study of patients old and young with non-Hodgkin's lymphoma].

1992 • 3 citations